1. Home
  2. BIO vs PCVX Comparison

BIO vs PCVX Comparison

Compare BIO & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$264.92

Market Cap

7.1B

Sector

Industrials

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$53.88

Market Cap

6.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIO
PCVX
Founded
1952
2013
Country
United States
United States
Employees
7450
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
6.1B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BIO
PCVX
Price
$264.92
$53.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
7
Target Price
$358.50
$98.33
AVG Volume (30 Days)
235.7K
1.1M
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2.74
N/A
Revenue Next Year
$3.05
N/A
P/E Ratio
$9.72
N/A
Revenue Growth
N/A
N/A
52 Week Low
$211.43
$28.09
52 Week High
$343.12
$75.33

Technical Indicators

Market Signals
Indicator
BIO
PCVX
Relative Strength Index (RSI) 40.24 41.02
Support Level $239.33 $42.30
Resistance Level $289.61 $56.04
Average True Range (ATR) 7.46 2.50
MACD 0.44 -0.85
Stochastic Oscillator 19.99 7.80

Price Performance

Historical Comparison
BIO
PCVX

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

Share on Social Networks: